Concerns With Analysis in Study of Tecovirimat for Mpox Among People With HIV
JAMA Internal Medicine · 01.06.2024 · 184 (6) · 706
DOI: 10.1001/jamainternmed.2024.0992 ↗Kurz gefasst
Kommentar in der Zeitschrift JAMA Internal Medicine, erschienen am 01.06.2024. Verfasst von Yu-Hsin Ting und 2 weiteren Autor:innen. Beteiligte Einrichtung: Harvard T. H. Chan School of Public Health, Boston, Massachusetts. Hauptthemen laut MEDLINE: HIV Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
- Division of Pulmonary, Critical Care and Sleep Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York.
- Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
Zitieren
APA
Ting, Y. H., Lee, Y. C., & Chang, K. Y. (2024). Concerns With Analysis in Study of Tecovirimat for Mpox Among People With HIV. JAMA Internal Medicine, 184(6), 706. https://doi.org/10.1001/jamainternmed.2024.0992
Vancouver
Ting YH, Lee YC, Chang KY. Concerns With Analysis in Study of Tecovirimat for Mpox Among People With HIV. JAMA Internal Medicine. 2024;184(6):706. doi:10.1001/jamainternmed.2024.0992
BibTeX
@article{Ting2024,
author = {Ting, Yu-Hsin and Lee, Yu-Che and Chang, Ko-Yun},
title = {Concerns With Analysis in Study of Tecovirimat for Mpox Among People With HIV},
journal = {JAMA Internal Medicine},
year = {2024},
volume = {184},
number = {6},
pages = {706},
doi = {10.1001/jamainternmed.2024.0992}
}
EUVIMED